Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients

被引:12
|
作者
Gruson, Damien [1 ,2 ,3 ]
Ferracin, Benjamin [2 ,3 ]
Ahn, Sylvie A. [4 ,5 ]
Rousseau, Michel F. [4 ,5 ]
机构
[1] Clin Univ St Luc, Inst Rech Expt & Clin, Pole Rech Endocrinol Diabet & Nutr, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Lab Med, B-1200 Brussels, Belgium
[3] Catholic Univ Louvain, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Div Cardiol, B-1200 Brussels, Belgium
[5] Catholic Univ Louvain, Inst Rech Expt & Clin, Div Cardiol, Pole Rech Cardiovasc, B-1200 Brussels, Belgium
关键词
FGF-23; Galectin-3; ST2; NT-proBNP; BNP; Biomarker; Heart failure; Prognosis; EXPRESSION; PREDICTOR;
D O I
10.1016/j.ijcard.2015.04.074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:185 / 187
页数:3
相关论文
共 50 条
  • [41] Soluble ST2 in Patients with Nonvalvular Atrial Fibrillation and Prediction of Heart Failure
    Chen, Changxi
    Qu, Xiang
    Gao, Zhan
    Zheng, Gaoshu
    Wang, Yi
    Chen, Xiao
    Li, Haiying
    Huang, Weijiang
    Zhou, Hao
    INTERNATIONAL HEART JOURNAL, 2018, 59 (01) : 58 - 63
  • [42] Soluble ST2 as a possible biomarker for inflammation in patients with acute heart failure
    Lai, Jiacheng
    Huang, Chongjian
    Li, Bin
    Han, Yongsheng
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (03) : 186 - 192
  • [43] Galectin-3 is associated with severe heart failure and death: A hospital-based study in Chinese patients
    Wang, Na
    Dang, Minyan
    Zhang, Wenzhi
    Lei, Yan
    Liu, Zhaochuan
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 91 (05)
  • [44] Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
    Yalta, Kenan
    Zorkun, Cafer
    INDIAN HEART JOURNAL, 2018, 70 (01) : 196 - 196
  • [45] Soluble ST2 may possess special superiority as a risk predictor in heart failure patients
    Zhou, Heng
    Ni, Jian
    Yuan, Yuan
    Deng, Wei
    Bian, Zhou-Yan
    Tang, Qi-Zhu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 186 : 146 - 147
  • [46] Soluble ST2 for predicting heart failure, atrial fibrillation and death in patients with coronary heart disease with or without renal insufficiency
    Li, Huiying
    Zhu, Qiwei
    Bai, Jing
    Chen, Jianqiao
    Zhu, Zifan
    Hao, Benchuan
    Wang, Wei
    Bai, Yongyi
    Liu, Hongbin
    HELIYON, 2024, 10 (09)
  • [47] Does the ST2 Level in Pediatric Heart Failure Patients Correlate with Cardiovascular Events and Mortality?
    Sulu, Ayse
    Uner, Gulcan
    Kosger, Pelin
    Ucar, Birsen
    CHILDREN-BASEL, 2024, 11 (06):
  • [48] The relationship between peripheral blood soluble ST2, BNP levels, cardiac function, and prognosis in patients with heart failure
    Gu, Di
    Zhou, Jianzhong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (04): : 2878 - 2884
  • [49] Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals CHS (Cardiovascular Health Study)
    Ix, Joachim H.
    Katz, Ronit
    Kestenbaum, Bryan R.
    de Boer, Ian H.
    Chonchol, Michel
    Mukamal, Kenneth J.
    Rifkin, Dena
    Siscovick, David S.
    Sarnak, Mark J.
    Shlipak, Michael G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (03) : 200 - 207
  • [50] Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
    Pascual-Figal, Domingo A.
    Ordonez-Llanos, Jordi
    Tornel, Pedro L.
    Vazquez, Rafael
    Puig, Teresa
    Valdes, Mariano
    Cinca, Juan
    Bayes de Luna, Antoni
    Bayes-Genis, Antoni
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (23) : 2174 - 2179